In a recent Sermo survey of 100 U.S. urologists, 57 percent indicated they were unable to treat patients in the last 12 months due to a lack of access to TICE ® BCG. The alternative BCG source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback